EMEA-002127-PIP01-17

Key facts

Invented name
Active substance
Recombinant humanised IgG4 monoclonal antibody against MSRV-Envelope protein (GNbAC1)
Therapeutic area
Neurology
Decision number
P/0371/2017
PIP number
EMEA-002127-PIP01-17
Pharmaceutical form(s)
Solution for infusion
Condition(s) / indication(s)
Treatment of multiple sclerosis
Route(s) of administration
Intravenous use
Contact for public enquiries
GeNeuro SA
Tel. +41  225524800
E-mail: contact@geneuro.com
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating